INVO Bioscience Inc

NASDAQ:INVO  
2.98
-0.15 (-4.79%)
Earnings Announcements

INVO Bioscience Reports Q3 2021 Results

Published: 11/15/2021 21:33 GMT
INVO Bioscience Inc (INVO) - Invo Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update.
Q3 Revenue $218,900.
Qtrly Loss per Share $0.24.
Revenue is expected to be $0.26 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $1.37 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.